Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (3046)	8/26/2010 12:36:25 PM
From: Jibacoa	Respond to of 3722

ALXA was also up 10.39% at its intraday H at 10:10am, but is up only 6.81% at present.<g> Volume is almost 2x its ADV bigcharts.marketwatch.com The stock has now closed its Aug 5 DG and earlier this morning was able to trade for a while above the resistance at the $3 level, but the nearest resistance to watch is from the $3.10 to $3.15 level.<g> bigcharts.marketwatch.com They announced that it has licensed its Staccato nicotine technology to CYPB, which is intended to help smoking cessation by delivering nicotine via inhalation. However, the important news pending is the FDA hearing of their AZ-004 (Staccato Loxapine), which is expected around the 2nd week in October.<g> They also have in their pipeline AZ-007 for patients with midnite insomnia, which combines their Staccato system with zalepiom. The ACTAY is $6.58 However, the stock has a good amount of resistance at the $4 level and I would keep the previous TT at that point.<g> bigcharts.marketwatch.com Bernard